Balyasny Asset Management’s Day One Biopharmaceuticals DAWN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-133,641
| Closed | -$1.06M | – | 2101 |
|
|
2025
Q1 | $1.06M | Buy |
133,641
+104,186
| +354% | +$826K | ﹤0.01% | 1335 |
|
|
2024
Q4 | $373K | Buy |
+29,455
| New | +$373K | ﹤0.01% | 1564 |
|
|
2024
Q2 | – | Sell |
-53,152
| Closed | -$878K | – | 2013 |
|
|
2024
Q1 | $878K | Buy |
53,152
+37,547
| +241% | +$620K | ﹤0.01% | 1307 |
|
|
2023
Q4 | $228K | Buy |
+15,605
| New | +$228K | ﹤0.01% | 1708 |
|
|
2023
Q1 | – | Sell |
-9,883
| Closed | -$213K | – | 2285 |
|
|
2022
Q4 | $213K | Buy |
+9,883
| New | +$213K | ﹤0.01% | 1677 |
|